Pharm/ drug need to know Flashcards
Epinephrine (Adrenalin)
Drug Class: Sympathomimetic: adrenergic agonist
Dosage: Anaphylaxis; Adult: subQ 0.3-0.5 mL of 1:1000 PRN
Contraindications: Cardiac tachydysrhythmias, cerebral arteriosclerosis, pregnancy, narrow-angle glaucoma, cardiogenic shock.
Caution: Hypertension, prostatic hypertrophy, hyperthyroidism, pregnancy, diabetes mellitus (hyperglycemia could result).
Drug-Lab-Food Interactions: Drug: Increased effects with tricyclic antidepressants and MAOIs. Methyldopa and beta-blockers antagonize epinephrine effects. Digoxin may cause dysrhythmias with epinephrine. Lab: Increases blood glucose and serum lactic acid.
Pharmacokinetics of Epinephrine: Used in emergency anaphylaxis because it can be administered via various routes: topically, subcutaneous injection, inhalation, instillation, and intracardiac. It cannot be given orally. Epinephrine is metabolized by the liver and excreted in the urine.
Pharmacodynamics of Epinephrine: The onset of action and peak concentration times are rapid.
Therapeutic Effects/Uses: To treat allergic reaction, anaphylaxis, asthma, bronchospasm, severe hypotension, cardiac arrest.
Mode of Action: Acts on alpha and beta-receptors. Promotes CNS and cardiac stimulation and bronchodilation. Strengthens cardiac contraction. Increases cardiac rate and cardiac output. Reduces mucosal congestion by inhibiting histamine release. Reverses anaphylactic reactions.
Albuterol (Proventil, Ventolin)
Drug Class: Beta2-adrenergic agonist
Dosage: Adult PO: 2-4 mg. t.i.d./q.i.d; max: 32 mg/d in 4 divided doses
Inhalation: 1-2 puffs q 4-6 hrs. PRN
Contraindications: cardiac dysrhythmias, coronary artery disease.
Caution: Severe cardiac disease, hypertension, hyperthyroidism, diabetes mellitus, renal dysfunction, older adults, pregnancy.
Drug-Food-Interactions: Drug: Increased effect with other Sympathomimetics. May increase effect with MAOIs and tricyclic antidepressants. Antagonized effect with beta-blockers. Lab: May increase glucose level slightly. May decrease serum potassium level.
Pharmacokinetics of Albuterol: Albuterol is absorbed by the GI tract and metabolized by the liver. Half-life for oral route is 2.7 to 6 hours and half-life of inhalation route is 3.5 hours
Pharmacodynamics of Albuterol: The primary use of albuterol is to prevent and treat bronchospasm. Tremors, restlessness, and nervousness are common side effects or oral or inhalation albuterol. If albuterol is taken with MAOIs, hypertensive crisis can result.
Therapeutic Effect/Uses: To treat asthma and prophylaxis and treatment of bronchospasm
Mode of Action: Stimulates beta 2-adrenergic receptors in the lungs, which relaxes the bronchial smooth muscle causing bronchodilation.
Side effects: Tremor, dizziness, nervousness, restlessness, sweating, nausea, diarrhea, muscle cramps
Adverse reactions: Palpitations, tachycardia, HTN, infection, hyperglycemia. Life-threatening: cardiac dysrhythmias, Stevens-Johnson Syndrome, angioedema
Atenolol
Drug Class: Beta1-adrenergic blocker
Dosage: Hypertension/angina: Adult PO: 25-50 mg/day; may increase to 100 mg/day
Contraindications: Sinus bradycardia, heart block, cardiogenic shock, pulmonary edema, acute bronchospasm, cardiac failure, pregnancy, lactation.
Caution: renal dysfunction, diabetes mellitus.
Drug-Lab-Food Interactions: Drug: Increased absorption with atropine and other anticholinergics. Decreased effects with NSAIDS, increased risk of hypoglycemia with insulin and sulfonylureas. Increased hypotension with prazosin and terazosin. Increased lidocaine and verapamil levels with toxicity.
Pharmacokinetics: Atenolol is 50% absorbed form the GI tract. It has a half-life of 3 to 6 days and is excreted in the urine and feces.
Pharmacodynamics: decreases the heart rate, peripheral vascular resistance, force of cardiac contractions, cardiac output, and blood pressure. It is available in tablets and IV. The drug is effective for dosing once a day.
Therapeutic Effects/Uses: To treat HTN, angina, and prophylaxis and treatment of acute MI.
Mode of Action: Selectively blocks beta1-adrenergic receptor sites, decreases sympathetic outflow to the periphery, suppresses renin-angiotensin-aldosterone system
Drug Interactions: NSAIDS decrease the effect of atenolol. Atropine increases the absorption of atenolol.
Side Effects: Drowsiness, dizziness, depression, weakness, nausea, diarrhea, cool extremities, ED
Adverse Reactions: bradycardia, hypotension, HF, dyspnea.
Life-threatening: bronchospasm, dysrhythmia, thrombocytopenia
** A selective beta 1 blocker that is one of the most frequently prescribed drugs in the United States. Atenolol decreases sympathetic outflow to the periphery and suppresses the renin-angiotensin-aldosterone system response. It is contraindicated in bradycardia, heart block, cardiogenic shock, pulmonary edema, acute bronchospasm, and pregnancy.
Patients should be taught to rise slowly d/t orthostatic hypotension.**
Bethanechol Chloride
Drug Class: Cholinergic – parasympathomimetic
Dosage: PO:10-15 mg tid/qid; Max: 200 mg/day. Subcut: 5 mg tid/qid; max: 40 mg/d
Contraindications: Intestinal or urinary tract obstruction, IBS, severe bradycardia, hypotension, COPD, asthma, peptic ulcer, hyperthyroidism, seizure, parkinsonism.
Drug-Lab-Food Interactions: Drug: Decreases Bethanechol effect w/ antidysrhythmic; ganglionic blocking agents cause significant hypotension following severe abdominal symptoms.
Atropine counteracts Bethanechol action. Lab: False test results (amylase, lipase).
Pharmacokinetics: Absorption: Poorly absorbed PO
Pharmacodynamics: PO: Onset 0.5 – 1.5 hours. Peak: 1-2 hours. Duration: 4-6 hours.
Therapeutic Effects/Uses: To treat urinary retention and neurogenic bladder.
Mode of action: Stimulates the cholinergic (muscarinic) receptors; promotes contraction of the bladder; increases GI secretions and peristalsis, pupillary constriction, and bronchoconstriction.
Side Effects: N/V/D, abdominal cramps, hypersalivation, sweating, HA, dizziness, flushing, urinary urgency and frequency.
Adverse reactions: Tachycardia weakness. Life threatening: Bronchospasm
Atropine
Drug Class: Anticholinergic: parasympatholytic
Dosage: Bradycardia: IV: 0.5-1 mg, repeat q 6 min., max: 2mg. Preoperative: PO: 2 mg, 20-30 min before anesthesia
Contraindications: Narrow angle glaucoma, obstructive GI disorders, paralytic ileus, ulcerative colitis, tachycardia, BPH, myasthenia gravis, MI.
Drug Label/Food Interactions: Increased effect with antihistamines, TCAs, amantadine, quinidine, and many more
Pharmacokinetics: Absorption: PO.IM well absorbed. Distribution: Crosses the placenta. Metabolism: t1/2: 2-3 hours. Excretion: 75% excreted in the urine
Pharmacodynamics: PO: onset O.5-1 hour. Duration: 4hours. IV: onset: immediate Peak: 5minutes
Therapeutic Effects/Uses: Preoperative medication to reduce salivation. Increase the heart rate in bradycardia (by blocking vagus stimulation). To dilate pupils for eye exams.
Side effects: Dry mouth, nausea, headache, amnesia, constipation, dry skin, urinary retention, mydriasis, photophobia, palpitation.
Adverse reactions: Tachycardia, hyper/hypotension, seizures. Life threatening: ventricular fibrillation, laryngospasm, Stevens-Johnson syndrome, coma
** Atropine is a classic anticholinergic –or muscarinic antagonist– medication. Atropine is primarily useful as a pre-op medication to decrease salivary secretions and as an agent to increase heart rate when bradycardia is present. It increases the heart rate by blocking vagus stimulation. Atropine can also be used as an antidote for Bethanechol.**
Benztropine
Drug Class: Antiparkinsonism: anticholinergic agent
Dosage: Antiparkinsonism: Adult: PO/IM 0.5-0.6 mg/day at bedtime; max: 8 mg/day. Extrapyramidal symptoms (except tardive dyskinesia): PO/IM/IV: 1-4 mg q daily/bid; max: 8 g/day.
Contraindications: Closed-angle glaucoma, tardive dyskinesia, dementia, myasthenia gravis, contraindicated for children. Caution: Tachycardia, cardiac disease, autonomic neuropathy, prostatic hypertrophy, psychosis.
Drug-Lab-Food Interactions: Drug: increase anticholinergic effects with phenothiazines, tricyclic antidepressants, and other anticholinergics.
Pharmacokinetics: Absorption: PO, well-absorbed. Distribution: Protein binding unknown. Metabolism: t ½ unknown. Excretion: in urine.
Pharmacodynamics: PO: Onset 1 hr.
Therapeutic Effects/Uses: To decrease involuntary symptoms of Parkinson’s or drug-induced Parkinson’s.
Mode of Action: Blocks cholinergic (muscarinic) receptors and decreases acetylcholine to reduce excess cholinergic activity (involuntary movements), also blocks dopamine reuptake to prolong dopamine effects and decrease involuntary movements.
Side Effects: N/V, dry mouth, constipation, anhidrosis, dizziness, HA, drowsiness, blurred vision, confusion, depression, hallucinations, hyphohidrosis, weakness, hyperthermia, paresthesia.
Adverse Reactions: Tachycardia, urinary retention, ocular hypertension. Life-threatening: Ileus.
Tolterodine Tartrate
Drug Class: anticholinergic
Dosage: Immediate release; Adult: 1-2 mg bid; max: 4 mg/day. Extended release: Adult: PO: 2-4 mg/day; 4 mg/day
Contraindications: Hypersensitivity, urinary retention, gastric paresis, GI obstruction, glaucoma, lactation.
Caution: Alcoholism, cardiovascular disease, HTN, bradycardia, heart failure, GERD, paralytic ileus, ulcerative colitis, diabetes, myasthenia gravis, urinary tract obstruction, prostatic hypertrophy, renal or hepatic dysfunction.
Drug-Lab-Food-Interactions: Drug increased effect with amantadine, amoxapine, bupropion, clozapine, cyclobenzaprine, disopyramide, maprotiline, olanzapine, H1 blockers, phenothiazines, TCAs. Decreased effects with azole antifungals, macrolide antibiotics, cyclosporine, fluoxetine.
Pharmacokinetics: Absorption: GI absorption decreased with food intake. Distribution: Protein binding 96%. Metabolism: t1/2 2-4 hrs. Excretion: Urine and feces.
Pharmacodynamics: PO: Onset Unknown.
Therapeutic Effects/Uses: To decrease urinary frequency, urgency, incontinence. Mode of Action: Blocks cholinergic (muscarinic) receptors selectively in the urinary bladder.
Side Effects: Dry mouth, eyes, and skin; headache, drowsiness, dizziness, vertigo, blurred vision, confusion, diarrhea, abdominal pain, constipation, dyspepsia, dysuria, fatigue, weight gain, urinary retention .
Adverse Reactions: Angioedema, chest pain, tachycardia, peripheral edema. Life threatening: Stevens-Johnson syndrome.
Methylphenidate
Drug Class: Amphetamine-like drug. CNS stimulant.
Dosage: ADHD: Children > 6 yrs.: PO 5-20mg before breakfast and lunch; may increase dosage weekly by 5-10mg. Max: 60mg/day. Adults: PO 20-30 mg in divided doses before breakfast and lunch. Max: 60 mg/day. Narcolepsy: PO 10-60 mg /day, divided doses 30 minutes before meal.
Contraindications: Hyperthyroidism, anxiety, history of seizures, coronary artery disease, hypertension, Tourrette’syndrome, glaucoma, psychosis, depression.
Caution: Not to be used in children < 6 yrs. of age.
Drug-Lab-Food Interactions: May increase effects of sympathomimetics, psychostimulants, may reduce effect of antihypertensives. Increases effects of oral anticoagulants, barbiturates, anticonvulsants, antidepressants. Food: Caffeine may increase effects. Give 30 to 45 minutes before meals.
Therapeutic Effects/Uses: To correct hyperactivity caused by ADHD, increase attention span, and control narcolepsy.
Side Effects: Anorexia, dry mouth, vomiting, dizziness, insomnia, irritability, tremors, blurred vision, headache, anemia.
Adverse Reactions: Tachycardia, HTN, growth suppression, palpitations, seizures, transient weight loss in children.
Life threatening: Exfoliative dermatitis, stroke, thrombocytopenia, hepatotoxicity
Alprazolam (Xanax)
Drug Class: Sedative-hypnotic: benzodiazepine.
Dosage: Adult PO Initially 0.25-0.5 mg/day
Contraindications: Respiratory depression, acute alcohol intoxication, psychotic reactions, recent respiratory depressants, hypersensitivity. Caution: Older adults, sleep apnea, renal or liver dysfunction, depression, suicidal ideation, drug abuse.
Drug-lab-Food interactions: Drug Interactions: decreases respiration with alcohol, CNS depressants, azole antifungals (ketoconazole), antibiotics (erythromycin), cimetidine, diltiazem, verapamil increases blood levels of alprazolam, rifampin, phenytoin decrease blood levels of alprazolam, alprazolam increases digoxin and lithium levels. Food: Grapefruit juice increases alprazolam levels; green tea decreases alprazolam effects.
Therapeutic Effects/Uses: To treat anxiety and panic disorders.
Mode of Action: CNS depression, binds receptors in limbic system and reticular formation, increases GABA to GABA receptors, shifts chloride ions leading to less excitability and stabilizes neuronal membranes.
Side Effects: Lethargy, drowsiness, dizziness, HA, constipation, memory impairment, fatigue, agitation, ataxia, increases appetite, blurred vision, decreased libido, dry mouth, nausea, edema, weight gain/loss
Adverse reactions: Depression, tolerance, dependence, withdrawal, hypotension, tachycardia, seizures. Life-threatening: Hepatic failure, Stevens-Johnson Syndrome
Zolpidem Tartrate
Drug Class: Sedative-hypnotic: nonbenzodiazepine.
Dosage: Adult PO: 5-10mg hs (at bedtime); max: 10 mg/day
Contraindications: Hypersensitivity to benzodiazepine, respiratory depression, lactation. Caution: renal or liver dysfunction, mental depression, suicidal ideation, pregnancy, children, older adults, and debilitated individuals.
Drug-Lab-Food Interactions: Drug: Decreases CNS function with alcohol, CNS depressants, anticonvulsants, and phenothiazines; increased levels with azole antifungals; decreased levels with rifampin. Food: Decreases absorption.
Therapeutic Effects/Uses: To treat insomnia.
Mode of Action: CNS depression, neurotransmitter inhibition.
Side Effects: Drowsiness, lethargy, headache, hot flashes, hangover (residual sedation), irritability, dizziness, ataxia (lack of coordination of voluntary muscle movements), visual disturbances, anxiety, mental depression, N/V, edema, anterograde amnesia, memory impairment, nightmares, binge eating, erectile dysfunction.
Adverse reactions: Tolerance, psychological or physical dependence, sleep-related behavior, hypotension, angioedema, dysrhythmias, suicidal ideation. Life-threatening: Pulmonary edema, renal failure
** Zolpidem (Ambien) is a nonbenzodiazepine that differs in chemical structure from benzodiazepines. It is used for short term treatment of insomnia (<10 days). When prescribed to older adults, the dose of zolpidem should be decreased.**
Phenytoin (Dilantin)
Drug Class: Anticonvulsant: hydantoin. Trade name: Dilantin.
Dosage: Adult: PO 4-7 mg/kg/day. IV: Loading dose: 15-20 mg/kg/day; max: 30 mg/kg. Child: 5 mg/kg/day in 2-3 divided doses.
Therapeutic serum range: 10-20 mcg/mL. Toxic level: 30-50 mcg/mL
Contraindications: Hypersensitivity, heart block, bradycardia, Adams-Stokes syndrome.
Caution: Hyponatremia, hypotension, hypoglycemia, suicidal ideation, myasthenia gravis, thyroid disease, alcoholism, DM, renal and hepatic impairment, Asian.
Drug-Lab-Food Interactions: Drug: increases effects with cimetidine, isoniazid, and chloramphenicol, decrease effects with folic acid, calcium, antacids, sucralfate, vinblastine, and cisplatin. Decreases effects of: anticoagulants, oral contraceptives, antihistamines, corticosteroids, theophylline, cyclosporine, quinidine, dopamine, and rifampin. Food: Decreased effects of folic acid, calcium, and Vitamin D because absorption is decreased with phenytoin.
Therapeutic Effects/Uses: To prevent tonic-clonic seizures and complex partial seizures and status epilepticus.
Mode of Action: Reduces motor cortex activity by altering ion transport.
Side Effects: Headache, diplopia (double vision), confusion, dizziness, drowsiness, insomnia, fatigue, ataxia, tremor, rash, anorexia, N/V, gingival hyperplasia, pink-red/brown discoloration of urine.
Adverse reactions: Leukopenia, hepatic impairment, depression, hyperglycemia, bradycardia, peripheral neuropathy, purple glove syndrome.
Life threatening: Aplastic anemia, thrombocytopenia, agranulocytosis, Stevens-Johnson syndrome, hypotension, ventricular fibrillation, suicidal ideation.
Carbidopa-Levodopa (Sinemet)
Drug Class: Antiparkinsonian: Dopamine replacement. Trade name: Sinemet.
Dosage: Adult: PO initially 1 tablet containing 25mg carbidopa/100mg levodopa t.i.d/q.i.d.; maintenance: 25/250 mg t.i.d./q.i.d.; max: 8 tablets per day. Extended release: 50mg carbidopa/200 mg levodopa b.i.d.
Contraindications: Narrow-angle glaucoma, severe cardiac, renal, hepatic disease; suspicious skin lesions (activates malignant melanoma), MAOI therapy. Caution: Peptic ulcer, impulse control syndrome, orthostatic hypotension, psychosis, seizure disorder, suicidal ideation.
Drug-Lab-Food Interactions: Drug: Increases hypertensive crisis with MAOIs. Decreased levodopa effect with anticholinergics and antipsychotics. Lab: May increase BUN, AST, ALT, ALP, LDH. Food: High-protein foods decrease levodopa absorption
Therapeutic Effects/Uses: To treat parkinsonism; to relieve tremors and rigidity. Mode of Action: Transmission of levodopa to brain cells for conversion to dopamine; carbidopa blocks the conversion of levodopa to dopamine in the intestine and peripheral tissues.
Side Effects: Anorexia, N/V, dysphagia, dyskinesia, erythema, fatigue, dizziness, HA, dry mouth, constipation, bitter taste, twitching, blurred vision, insomnia, excess dark sweating, urine discoloration (red, brown, black).
Adverse reactions: Involuntary movements, angioedema, palpitations, orthostatic hypotension, urinary retention, priapism, psychosis, severe depression with suicidal ideation, hallucinations, sudden sleep onset, impulse control symptoms.
Life-threatening: agranulocytosis, hemolytic anemia, leucopenia, thrombocytopenia, cardiac dysrhythmias, neuroleptic malignant syndrome (w/ abrupt discontinuation).
Rivastigmine
Drug Class: Acetylcholinesterase inhibitor. Trade Name: Exelon
Dosage: Adult: PO: Initially: 1.5 mg bid; increase gradually. Maintenance: 3-6 mg bid; max: 12 mg/day.
Caution: Liver and renal disease, urinary tract obstruction, orthostatic hypotension, bradycardia, asthma, COPD, seizures, peptic ulcer disease.
Drug-Lab-Food Interactions: Drug: Increased effect of theophylline, general anesthetics; TCAs decrease effect; Increased effect with cimetidine; NSAIDS increase GI effects. Tobacco increases clearance of rivastigmine.
Pharmacokinetics: Absorption: PO: Food decreases absorption rate.
Therapeutic effects/Uses: Improves memory loss in Alzheimer disease. Mode of Action: Elevates acetylcholine concentration.
Side Effects: Anorexia, N/V, diarrhea or constipation, abdominal pain, weight loss, dizziness, HA, depression, confusion, peripheral edema, dry mouth, dehydration, nystagmus.
Adverse reactions: Seizures, bradycardia, orthostatic hypotension, cataracts, MI, heart failure.
Life-threatening: Hepatotoxicity, dysrhythmias, suicidal ideation, Stevens-Johnson syndrome.
Pyridostigmine
Drug Class: Acetylcholinesterase (AChE) inhibitor Trade name: Mestinon
Dosage: Adult: PO: 60-120 mg in 5 to 6 doses per day; max: 600 mg/day in divided doses. Sustained release (SR):180-540 mg daily/b.i.d, with at least 6 hours between doses; max: 1.5 g/day. Adult: IM/IV: 2 mg q 2-3 hours. Child: PO:1mg/kg/day every 4-6 h; max single dose:10 mg. Must be administered on time.
Contraindications: GI and GU obstruction, ileus, bladder obstruction Caution: Asthma, bradycardia, seizure disorder, peptic ulcer, cardiac arrhythmias, renal impairment, hyperthyroidism, pregnancy, breastfeeding.
Drug-Lab-Food Interactions: Drug: Corticosteroids, neuromuscular blockers, aminoglycosides, local anesthetics, magnesium salts; increased toxicity with AChE inhibitors, atropine, tetracyclines, polymyxin B, bacitracin, digoxin, quinidine, and insecticides containing malathion; atropine decreases the effect of pyridostigmine.
Therapeutic Effects/Uses: To control and treat MG, for neuromuscular blockade reversal, and for nerve gas (soman) exposure prophylaxis.
Mode of action: Transmission of neuromuscular impulses by preventing destruction of acetylcholine. Preserves muscle strength.
Side Effects: N/V/D, HA, blurred vision, dizziness, abdominal pain, excess saliva & sweating, rash, miosis (constricted pupils).
Adverse reactions: Hypotension, bradycardia. Life-threatening: Dyspnea, bronchospasm, cardiac dysrhythmias, seizures.
** Pyridostigmine increases muscle strength with muscular weakness resulting from MG.**
Cyclobenzaprine (Flexeril)
Drug Class: Centrally acting muscle relaxant Trade name: Flexeril
Dosage: Adult: PO: 5-10 mg tid; max: 30mg/day. Treatment beyond 2-3 wk is not recommended
Contraindications: Acute MI, AV blocks, bradycardia, bundle branch block, cardiac arrhythmias, children, HF, hyperthyroidism, HTN, hypokalemia, paralytic ileus, concurrent use of MAOI therapy or within 14 days after discontinuation.
Caution: Seizure disorder, alcohol, CNS depressants, glaucoma, prostatic hypertrophy, urinary retention, hepatic dysfunction, breastfeeding, driving or operating machinery, morbidity in geriatric pts, sunlight UV exposure
Drug-lab-Food Interactions: Drug: Increased CNS depression with alcohol, kava, valerian, barbiturates, TCAs, and other CNS depressants. Food: Take with food or milk to decrease GI effects.
Therapeutic effects/Uses: For short-term treatment of muscle spasms.
Mode of Action: relieves muscle spasms through a central action, possibly at brain stem level.
Side Effects: Anticholinergic effects (blurred vision, constipation, dry mouth, tachycardia, urinary retention); arrhythmias, confusion, drowsiness, dizziness, headache, nausea, nervousness, unpleasant taste
Adverse reactions: Allergic reactions, angioedema, MI, seizures, ileus.
Phenothiazine (Prolixin)
Drug Class: Antipsychotic: Neuroleptic Piperazine Phenothiazine Trade name: Prolixin
Dosage: Psychosis: Adult: PO 0.5-10 mg/day; max: 40mg/day.IM, subQ: 2.5-10mg/day; max:100 mg/day. Older adults: PO: 1-2.5 mg /day; max: 40mg/day. Decanoate: 12.5mg q3wk
Contraindications: Hypersensitivity, subcortical brain damage, severe CNS depression, coma.
Caution: Dysrhythmias, paralytic ileus, urinary retention, BPH, leukopenia, neutropenia, agranulocytosis, hepatic and renal damage, hypotension, dementia, glaucoma, parkinsonism, seizure disorder.
Drug-Lab-Food Interaction: Drug: Increases effects when taken with alcohol and other CNS depressants. Lithium and beta blockers increase effects. Herbal: kava kava may increase dystonia.
Therapeutic effects/Uses: To manage symptoms of psychosis including schizophrenia.
Mode of Action: Blocks dopamine receptors in the brain and controls psychotic symptoms.
Side Effects: Sedation, dizziness, headache, dry mouth, blurred vision, excess sweating, weight gain, constipation, urinary retention, peripheral edema, sexual dysfunction
Adverse reactions: Hypertension, hypotension, tachycardia, ileus, EPS (including TD), seizures, psychosis Life-threatening: agranulocytosis, leukopenia, neutropenia, hepatotoxicity, bronchospasm, dysrhythmias, NMS
Haloperidol (Haldol)
Drug Class: Anti-psychotic: Neuroleptic (non-phenothiazine) Trade name: Haldol
Dosage: Adult PO: initially 0.5-5 mg bid/tid; maint: 10-15 mg/d; max: 100 mg/d. Deconate: Adult: IM: Max 100 mg 1st dose, 450 mg subsequent monthly doses
Contraindications: Narrow angle glaucoma, severe hepatic, renal, cardiovascular disease; bone marrow depression, Parkinsonism, blood dyscrasias, CNS depression, subcortical brain damage, coma.
Caution: Alcoholism, dementia, glaucoma, dehydration, CAD, liver and renal damage, neutropenia, leukopenia.
Drug-Lab-Food Interactions: Drug: Increases sedation with alcohol, CNS depressants; increase toxicity with anticholinergics, CNS depressants, lithium. Decreased effects with phenobarbital, carbamazepine, and decreased effects with caffeine.
Therapeutic Effects/Uses: To treat acute and chronic psychosis, ADHD, schizophrenia, Tourette syndrome.
Mode of Action: Alters the effect of dopamine on the CNS; mechanism for antipsychotic effects are unknown.
Side Effects: Drowsiness, orthostatic hypotension, HA, lethargy, tremor, dry mouth and eyes, blurred vision, insomnia, agitation, weight gain, sexual dysfunction.
Adverse Reactions: Tachycardia, seizures, urinary retention, EPS. Life-threatening: laryngospasm, bronchospasm, dysrhythmias, NMS, agranulocytosis, leukopenia, neutropenia.
Aripiprazole (Abilify)
Drug Class: Non-phenothiazine: Atypical Antipsychotic Trade name: Abilify
Dosage: Psychosis: Adult PO: 10-15mg/daily; may increase dose q 2 weeks; max: 30mg/day. Adolescent: PO 2mg/day; may increase q 2 days to max:30 mg/day.
Contraindications: Hypersensitivity, dehydration, alcohol intoxication, hypovolemia, agranulocytosis, neutropenia, leukopenia, HF, suicidal ideation, MI, DM, hyperglycemia, hypotension, seizures, Parkinsonism.
Caution: dysrhythmias, dementia, CNS depression, hyperglycemia, hypotension, parkinsonism, seizures, agranulocytosis, neutropenia, leukopenia
Drug-Lab-Food Interactions: Drug: Antidiabetic agents decrease Abilify drug levels and increase risk of hyperglycemia. Alpha blockers and antihypertensives increase risk of hypotension; other antipsychotics increase risk of NMS, EPS, anticholinergic effects, hypotension, and seizures. SSRIs may increase risk of serotonin syndrome. Food: Grapefruit juice may increase blood levels. Herbal: St. John’s wort may decrease blood levels. Lab: Increased blood glucose.
Therapeutic Effects/Uses: To manage schizophrenia, bipolar disorder, autism, depression, Tourette syndrome.
Mode of Action: Interferes with the binding of dopamine to dopamine (D2) and serotonin receptors.
Side Effects: drowsiness, memory impairment, weight gain/loss, HA, fatigue, blurred vision, photosensitivity, peripheral edema, amenorrhea, hyperglycemia, hypoglycemia, insomnia, anxiety, agitation, dizziness, constipation, N/V, sexual dysfunction.
Adverse Reactions: Orthostatic hypotension, tachycardia, EPS, dysrhythmias, seizures. Life -threatening: Suicidal ideation, NMS, agranulocytosis, leukopenia, laryngospasm
Lorazepam (Ativan)
Drug Class: Anxiolytic: Benzodiazepine Trade name: Ativan
Dosage: Anxiety: Adult PO: 2-6 mg/day; max: 10 mg/day. Older adults: PO 1-2mg/day; max:10mg/day.
Contraindications: Hypersensitivity, narrow-angle glaucoma.
Caution: Hepatic or renal dysfunction, alcohol intoxication, depression, seizures, CNS depression, pregnancy, suicidal ideation.
Drug-lab-Food Interactions: Drug: Increases CNS depression when taken with alcohol, CNS depressants and anticonvulsants; cimetidine increases lorazepam plasma levels, increases phenytoin levels, decreases levodopa levels; smoking and caffeine decreases antianxiety effects, oral contraceptives decrease effects
Therapeutic Effects/Uses: To control anxiety and to treat status ecliptics; for preoperative sedation, for insomnia, for substance withdrawal.
Mode of Action: Potentiates GABA effects by binding to specific benzodiazepine receptors and inhibiting GABA neurotransmission.
Side Effects: Drowsiness, dizziness, weakness, confusion, HA, blurred vision, N/V, anorexia, restlessness, hallucinations, anterograde amnesia, ataxia.
Adverse Reactions: HTN, hypotension, bradycardia, dependence, seizures. Life-threatening: Suicidal ideation, NMS, respiratory depression.